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Abstract: The current study was aimed at investigating the effect of Areca catechu nut dichloromethane fraction (7
mg/kg) on monoamines (serotonin and dopamine) modulation (5-hydroxytryptophan-induced tremors and
phenylethylamine-induced stereotypes) and its interaction with tyramine (cheese effect). The dichloromethane fraction
caused pronounced increase in 5-HTP-induced tremors (50%) with negligible PEA-induced stereotypes (20%).
Additionally, it did not produce a significant increase in the tyramine pressor effects. These results suggest that the
dichloromethane fraction of A. catechu nut primarily elevates serotonin levels (probably via monoamine oxidase A
inhibition) and does not induce cheese effect.
Keywords: Areca catechu nut; dichloromethane fraction; serotonin; dopamine; cheese effect.

INTRODUCTION
The Areca catechu nut is a famous chewing nut intended
for mastication in various parts of the globe, especially
the Indo-Pak subcontinent. An estimated 600 million
persons consume it daily (Nelson and Heischober, 1999)
making it the 4th most commonly used psychoactive
substance after caffeine, nicotine and alcohol (Gupta and
Ray, 2004). It has been used as anthelmintic, visceral
infections, diarrhea, dysentery, burns, ulcers, dentrifice,
stimulant, exhilarant, digestive, astringent, cardiac and
nervine tonic in past (Raghavan and Baruah, 1958). It has
also been reported to inhibit MAO-A activity (Dar and
Khatoon, 1997) and elevate 5-HT and NA levels (Abbas
et al., 2012) in rats favoring anti-depressant-like
properties. A. catechu alkaloids have been the focus of
investigation, particularly arecoline which has been
considered as an active constituent underlying most of the
biological activities elicited by nut (Nelson and
Heischober, 1999).
Monoamine oxidase inhibitors (MAOIs) are clinically
effective in the treatment of depressive disorders with a
better therapeutic potential outcome against atypical
depression (Liebowitz et al., 1988). Additionally, some
patients with typical endogenous depression who are
refractory to tri-cyclic antidepressants (TCAs) may
respond favorably to MAOIs (Freeman et al., 1993).
However, their use is restricted because of adverse effects
particularly cheese effects (Anderson et al., 1993)
induced by tyramine-rich diet (e.g. cheese and red wine)
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which is contraindicated in the patients undergoing nonselective monoamine oxidase inhibitors treatment.
Tyramine, a sympathomimetic amine induces release of
stored monoamines (such as noradrenaline and dopamine)
metabolized by the enzyme monoamine oxidase and if coadministered with MAOIs may cause hypertensive crisis
and trigger cluster headaches (McCabe, 1986). Therefore,
patient counseling and appropriate diet planning for
patients on MAOIs is critical to avoid such drug
interactions. Because of their selectivity towards MAO-A,
a new generation MAOIs (e.g. moclobemide) appeared to
be safer thereby, leaving MAO-B intact to deaminate
tyramine (Keller et al., 1987, Plenker et al., 1997). They
are well tolerated and have low liability for potentiating
the tyramine pressor effect (Dowson, 1987) and are as
effective as some TCAs such as chloroimipramine
(Civeira et al., 1990).
The current study was aimed at investigating the effect of
dichloromethane fraction of A. catechu nut on serotonin
and dopamine modulation in rats. The possibility of a
cheese effect was also explored using tyramine pressor
test. Phenelzine (irreversible and nonselective MAOI) and
moclobemide (reversible and selective MAO-A inhibitor)
were included as standard drugs.

MATERIALS AND METHODS
Chemicals
Phenelzine sulfate, phenylethylamine, L-5-hydroxytryptophan and tyramine hydrochloride were purchased
from Sigma USA. Moclobemide was a gift from Roche,
Pakistan.
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Animals
Either sex of Sprague Dawley rats (200-300g) were
provided by the animal house of Aga Khan University,
Karachi (Total number =120). They were kept under
standard condition (light/dark cycle of 12 h each and free
access to food and water). All experiments were
performed in accordance with the guidelines provided by
the National Institute of Health (NIH publication no. 8523, revised 1985). for the care and use of laboratory
animals.
Preparation of dichloromethane fraction
A.catechu nuts were purchased from a local market and
authenticated by a botanist at the University of Karachi. A
voucher specimen (No. 67278) was submitted to the
herbarium of the Department of Botany, University of
Karachi. The dichloromethane fraction was obtained as
described earlier (Dar and Khatoon, 2000).
L-5-HTP-induced tremors
Animals were intraperitoneally treated (n=10/group) with
saline (control group) or dichloromethane fraction of A.
catechu (7 mg/kg) or moclobemide (5 mg/kg) or
phenelzine (16 mg/kg). After 1 h of treatment, each
animal received injection of L-5-HTP (100 mg/kg, i.p.).
After 30 min, the generalized tremors were noted for 1 h
(Lessin, 1959).
PEA-induced sterotypes
Animals were intraperitoneally treated (n=10/group) with
saline (control group) or dichloromethane fraction of A.
catechu (7 mg/kg) or moclobemide (5 mg/kg) or
phenelzine (16 mg/kg). After 1 h of treatment
/administration, each animal received injection of PEA
(25 mg/kg, i.p.). After 15 min, animals were observed for
the presence of stereotyped behavior (mouth movements
and licking) for 1h (Braestrup et al., 1975).
Tyramine pressor test
The animals were anaesthetized (pentothal sodium, 70
mg/kg) and the trachea was intubated to facilitate
spontaneous respiration. The right carotid artery and left
jugular vein were cannulated and blood pressure was
recorded as described previously by (Dar et al., 1999).
The effect of tyramine (0.1, 0.3 and 0.5 mg/kg, n=5/group)
on blood pressure, heart rate and the duration of its
pressor effect were determined. After each dose of
tyramine, noradrenaline (0.5 µM/kg) was administered to
replenish its stores with an interval of 10 min.
The dose of tyramine that produced a rise of 30 mm Hg in
blood pressure was selected to study its interaction with
dichloromethane fraction, moclobemide and phenelzine as
described by (Caille et al., 1996). The IC50 values of
above mentioned compounds obtained from our earlier
antidepressant studies were used (Dar and Khatoon, 2000).
Animals were intraperitoneally treated (n=5/group) with
saline (control) or dichloromethane fraction of A. catechu
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(7 mg/kg) or moclobemide (5 mg/kg) or phenelzine (16
mg/kg). After 1 h of treatment animals were anaesthetized
for blood pressure recording as described before and
tyramine (0.3 mg/kg) was administered. The percent
increase in blood pressure (amplitude), heart rate and the
duration of pressor effect was noted and compared with
their respective control.

STATISTICAL ANALYSIS
The data was presented as mean ± S.E.M. Difference
between various means were computed by one-way
ANOVA using SPSS. In L-5-HTP-induced tremors and
PEA-induced sterotypes, n is 10 per group. In tyramine
pressor test, n is 5 per group.

RESULTS
Effect of A. catechu nut dichloromethane fraction,
moclobemide and phenelzine on potentiation of
a) L-5-HTP-induced tremor in rats
The L-5-HTP (100 mg/kg) did not induce tremors in rats.
However, in the presence of phenelzine (16 mg/kg),
moclobemide (5 mg/kg) or dichloromethane fraction (7
mg/kg) a 30%, 70% and 50% increase in tremors,
respectively was evident (table 1).
Table 1: Effect of A. catechu nut dichloromethane
fraction of, moclobemide and phenelzine on potentiation
of L-5-HTP-induce tremors in rats.
Treatment (mg/kg)
Dichloromethane fraction (7
mg/kg) + L-5-HTP (100 mg/kg)
Moclobemide (5 mg/kg)
+ L-5-HTP (100 mg/kg)
Phenelzine (16 mg/kg)
+ L-5-HTP (100 mg/kg)
Saline + L-5-HTP (100 mg/kg)

Percent of tremors
50
70
30
00

Number of animals per group (control and test) = 10.

b) PEA-induced stereotypes in rats
The PEA (25 mg/kg) did not induce stereotype behavior
in rats. However, in the presence of phenelzine (16 mg/kg)
and dichloromethane fraction (7 mg/kg), there was 80%
and 20% increase in behaviors, whereas moclobemide (5
mg/kg) did not induce any behavioural changes (table 2).
Effect of tyramine on blood pressure, heart rate and
duration of pressor effect in anesthetized rats
Intravenous administration of tyramine (0.1-0.5 mg/kg)
caused dose dependent increase in blood pressure, heart
rate and duration of pressor effect. At 0.5 mg/kg,
significantly maximum increase of 39±3.1% and 15±2.9%
was observed in blood pressure and heart rate of animals,
respectively, that was reversed to baseline after almost 7
min (table 3).
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Table 2: Effect of dichloromethane fraction of A. catechu
nut, moclobemide and phenelzine on potentiation of PEAinduce stereotypes in rats
Treatment (mg/kg)
Dichloromethane fraction 7
mg/kg + PEA 25 mg/kg
Moclobemide 5 mg/kg +
PEA 25 mg/kg
Phenelzine 16 mg/kg + PEA
25 mg/kg
Saline + PEA 25 mg/kg

Percent of stereotypes
20
00
80
00

Number of animals per group (control and test) = 10.

Effect of A. catechu nut, moclobemide and phenelzine
on blood pressure and duration in tyramine pressor test
Tyramine (0.3 mg/kg) caused an increase in blood
pressure (22±2.1%) that was reversed to baseline after 2
min without affecting the heart rate (table 4). Pretreatment
of animals with phenelzine induced a marked potentiation
in amplitude (45±0.5%) and duration (7.4±0.8%) of the
pressor effect of tyramine. Although the amplitude and
duration of tyramine pressor effect was also increased by
the pretreatment of moclobemide but increase in
amplitude (1.4x) and duration (2.7x) was less compared to
that of phenelzine. However, the pretreatment of animals
with dichloromethane fraction of A. catechu did not cause
a significant elevation in either amplitude or duration of
tyramine pressor effect.

DISCUSSION
The current study was aimed to investigate the effect of A.
catechu nut (dichloromethane fraction) on monoamines
(serotonin and dopamine) associated behaviors in rats.
The possibility of cheese effect was also explored using
tyramine pressor test.
The L-5-hydroxytryptophan is an amino acid and
precursor of monoamine neurotransmitter serotonin and
its elevated levels lead to a serotonin syndrome
characterized by symptoms such as tremors (Sallinen et
al., 1998). Our data showed that L-5-HTP (100 mg/kg)
alone did not induce tremors in rats (table-1). However, in
the presence of the dichloromethane fraction (7 mg/kg) a
50% increase in the tremors were noticeable indicating
that the effect of L-5-HTP has been potentiated. In other
words, the fraction has elevated the levels of serotonin in
rat brain. This is in agreement with our recent report
(Abbas et al., 2012) where serotonin levels in rat
hippocampus were raised following areca nut treatment.
Additionally, phenelzine (non-selective MAO inhibitor)
and moclobemide (selective MAO-A inhibitor) induced
30% and 70% increase in tremors, respectively suggesting
that MAO-A inhibitors has greater ability to potentiate L5-HTP effects most likely due MAO-A inhibition which
Pak. J. Pharm. Sci., Vol.27, No.2, March 2014, pp.303-307

is mainly responsible for degradation of serotonin. This
also led us to deduce that A. catechu nut (dichloromethane
fraction) is most likely a MAO-A inhibitor as reported
earlier (Dar and Khatoon, 2000).
Phenylethylamine is a naturally occurring substance in the
brain which elicits stereotype behavior (SB, repetitive
movements of head, neck and mouth) due to the release of
catecholamines, mainly dopamine (Naik et al., 1978).
PEA (25 mg/kg) did not induce SB in rats (table-2),
however, in the presence of dichloromethane fraction, a
20% increase in SB indicates that the PEA effect has
mildly potentiated levels of dopamine in the rat brain.
This is in agreement with the lack of a significant
alteration in hippocampal dopamine levels following
areca nut treatment (Abbas et al., 2012). Additionally, the
phenelzine 16 mg/kg (non-selective MAO inhibitor,)
induced 80% increase in SB and moclobemide 5 mg/kg
(selective MAO-A inhibitor,) 0%, respectively. This
suggests that MAO-B inhibitors have the potential of
enhancing the effect of PEA probably because MAO-B is
mainly responsible for degradation of dopamine. This also
led us to deduce that A. catechu nut (dichloromethane
fraction) is probably not an inhibitor MAO-B enzyme.
Tyramine (present in diet such as cheese), metabolized by
MAO, causes release of stored monoamines
(noradrenaline and dopamine) leading to increase in blood
pressure and heart rate (Iwata et al., 1997). Tyramine in
the presence of MAOIs (e.g. phenelzine) can lead to
adverse effect like cheese effect (hypertensive crisis). Our
data showed that tyramine (0.1-0.5 mg/kg) showed dose
dependent increase in blood pressure, heart rate and
duration of pressor effect (table-4). Pretreatment of
animals with phenelzine induced a marked potentiation in
amplitude (45±0.5%) and duration (7.4±0.8%) of the
pressor effect induced by tyramine. Although the
amplitude and duration of tyramine pressor effect was
also increased by the pretreatment of moclobemide, this
increase in amplitude (1.4 times) and duration (2.7 times)
was less as compared to that of phenelzine. These results
are in accordance with those reported by previous
investigators (Caille et al., 1996). However, the
pretreatment of animals with dichloromethane fraction of
A. catechu nut did not cause a significant elevation in
either amplitude or duration of tyramine pressor effects.
Likewise, BW-130U87 and RS-8359 which are potent,
reversible and selective inhibitors of rat and human brain
MAO-A have been known (Cooper et al., 1992, Iwata et
al., 1997). It is established that old generation MAOIs
(e.g. phenelzine) inhibit both MAO-A and B, thus
allowing a greater amount of tyramine to reach at the
sympathetic nerve endings and provoke a serious
hypertensive crisis. Whereas, the new reversible and
selective MAO-A inhibitors are safer, due to their
specificity in inhibiting only MAO-A (leaving the MAOB intact to deaminate tyramine). Thereby, minimizing the

305

Effect of dichloromethane fraction of areca catechu nut
Table 3: Effect of tyramine on percent increase of blood pressure, heart rate and the duration of pressor effect in
anesthetized rats
Dose (mg/kg)
0.1
0.3
0.5

Blood pressure (mm Hg)
12 ± 5.3n.s
20 ± 3.8**
39 ± 3.1***

Heart rate (beats/min)
1 ± 0.8n.s
11 ± 4.9n.s.
15 ± 2.9***

Duration of pressor effect (min)
0.9 ± 0.77n.s.
3.3 ± 1.7n.s.
6.9 ± 1.3**

Blood pressure (control) =118±6.9 mm Hg and heart rate 325 ± 12.6 beats per min. Values are means ± SEM of control animals
(n=5) and animals per dose (n=5). Asterisks indicate significant change (P<0.01** and P<0.005***) as compared to control and n.s.
represents non-significant differences.

Table 4: Effect of tyramine in the absence and presence of dichloromethane fraction of A. catechu nut, moclobemide
and phenelzine on blood pressure and the duration pressor effect.
Treatment
Tyramine (0.3 mg/kg)
Dichloromethane fraction + tyramine (0.3 mg/kg)
Moclobemide (5 mg/kg) + tyramine (0.3 mg/kg)
Phenelzine (16 mg/kg) + tyramine (0.3 mg/kg)

Percent increase in blood
pressure (mm Hg)
22 + 2.1
25 +2.1n.s
33 + 3.3*
45 + 0.5***

Duration of pressor effect (min)
2.1 + 0.1
2.2 + 0.2n.s.
2.6 + 0.2**
7.4 + 0.8***

Blood pressure (control) =126±2.9 mm Hg (n=25). Values are mean ± SEM. Asterisks indicate significant change (P<0.05*,
P<0.01** and P<0.005***) as compared to control (tyramine 0.3 mg/kg) and n.s represents non-significant differences.

risk of their side effects, particularly the cheese effect
(Bieck and Antonin, 1989, Fitton et al., 1992).
In conclusion, the dichloromethane fraction of A. catechu
nut possesses/contains monoamines (mainly serotonin)
with modulating potential without producing a detectable
cheese effect similar to that of moclobemide (MAO-A
inhibitor). Thus, the dichloromethane fraction has great
potential as lead for antidepressants drug discovery.

REFERENCES
Abbas G, Naqvi S, Erum S, Ahmed S and Dar A (2012).
Potential antidepressant activity of Areca catechu nut
via elevation of serotonin and noradrenaline in the
hippocampus of rats. Phytother. Res., 27: 39-45.
Anderson MC, Hasan F, Mccrodden JM and Tipton KF
(1993). Monoamine oxidase inhibitors and the cheese
effect. Neurochem. Res., 18: 1145-1149.
Bieck P and Antonin K (1989). Tyramine potentiation
during treatment with MAO inhibitors: brofaromine
and moclobemide vs irreversible inhibitors. J. Neural.
Transm., Supp, 28: 21.
Braestrup C, Andersen H and Randrup A (1975). The
monoamine oxidase B inhibitor deprenyl potentiates
phenylethylamine behaviour in rats without inhibition
of catecholamine metabolite formation. Eur. J.
Pharmacol., 34: 181-187.
Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R,
Charieras T, Grosset A, Rovei V and Jarreau FX
(1996). Befloxatone, a new reversible and selective
monoamine oxidase-A inhibitor. II. Pharmacological
profile. J. Pharmacol. Exp. Ther., 277: 265-277.

306

Civeira J, Cervera S, Giner J, Allen S, Hellstern K,
Malanowski H, Wirz R and Klär K (1990).
Moclobemide versus clomipramine in the treatment of
depression: A multicentre trial in Spain. Acta Psychiat.
Scand., 82: 48-49.
Cooper B, White H, Beek O, Norton R, Rigdon G,
Howard J, Kraemer G and Ferris R (1992). Overview
of the CNS pharmacology of BW 1370U87: A
chemically novel, reversible, selective MAO-A
inhibitor with potential to be a new antidepressant drug.
Drug Dev. Res., 25: 181-190.
Dar A, Khatoon S, Rahman G and Atta-ur-Rahman
(1997). Antidepressant activities of Areca catechu fruit
extract. Phytomedicine, 4(1): 41-45.
Dar A, Behbahanian S, Malik A and Jahan N (1999).
Hypotensive effect of the methanolic extract of
Mimusops elengi in normotensive rats. Phytomedicine,
6: 373-378.
Dar A and Khatoon S (2000). Behavioral and biochemical
studies of dichloromethane fraction from the Areca
catechu nut. Pharmacol. Biochem. Behav., 65: 1-6.
Dowson J (1987). MAO inhibitors in mental disease:
Their current status. J. Neural. Transm., 23: 121-138.
Fitton A, Faulds D and Goa K (1992). Moclobemide. A
review of its pharmacological properties and
therapeutic use in depressive illness. Drugs, 43: 561596.
Freeman E, Rickels K and Sondheimer S (1993).
Premenstrual symptoms and dysmenorrhea in relation
to emotional distress factors in adolescents. J.
Psychosom. Obst. Gyn., 14: 41-50.
Gupta P and Ray C (2004). Epidemiology of betel quid
usage. Ann. Acad. Med. Singapore, 33: 31-36.
Pak. J. Pharm. Sci., Vol.27, No.2, March 2014, pp.303-307

Shagufta Khan et al.
Iwata N, Püchler K and Plenker A (1997). Pharmacology
of the new reversible inhibitor of monoamine oxidase
A, RS-8359. Int. Clin. Psychopharm., 12: S3.
Keller H, Kettler R, Keller G and Prada M (1987). Shortacting novel MAO inhibitors: In vitro evidence for the
reversibility of MAO inhibition by moclobemide and
Ro 16-6491. N-S. Arch. Pharmacol., 335: 12-20.
Lessin A (1959). The pharmacological evaluation of
monoamine oxidase inhibitors. Biochem. Pharmacol., 2:
290-298.
Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ,
Harrison WM, Markowitz JS, Rabkin JG, Tricamo E,
Goetz DM and Klein DF (1988). Antidepressant
specificity in atypical depression. Arch. Gen.
Psychiatry, 45: 129-137
McCabe B (1986). Dietary tyramine and other pressor
amines in MAOI regimens: A review. J. Am. Diet.
Assoc., 86: 1059-1064.
Naik S, Kelkar MR and Sheth U (1978). Attenuation of
stereotyped
behaviour
by
sex
steroids.
Psychopharmacology, 57: 211-214.

Pak. J. Pharm. Sci., Vol.27, No.2, March 2014, pp.303-307

Nelson BS and Heischober B (1999). Betel nut: a
common drug used by naturalized citizens from India,
Far East Asia, and the South Pacific Islands. Ann.
Emergency Med., 34: 238-243.
Plenker A, Püchler K and Volz HP (1997). The effects of
RS-8359 on cardiovascular function in healthy subjects
and depressed patients. Int. Clin. Psychopharm., 12:
25-29.
Raghavan V and Baruah H (1958). Arecanut: India’s
popular masticatory-History, chemistry and utilization.
Econ. Bot., 12: 315-345.
Sallinen J, Haapalinna A, Viitamaa T, Kobilka B and
Scheinin M (1998). d-Amphetamine and l-5hydroxytryptophan-induced behaviours in mice with
genetically-altered expression of the α sub 2Cadrenergic receptor subtype. Neuroscience, 86: 959965.

307

